Moneyiar
Menu
Crypto ARC AKE XEC TAKE PRO PROVE

Palantir CTO Says AI Researchers Are Smoking to Signal Faith in Cancer Cure

Palantir CTO Shyam Sankar said on CBS that some AI researchers are smoking to signal their belief that AI will cure cancer, but he cited no evidence. His comments came amid criticism of effective altruism and growing public skepticism about AI’s benefits and risks.

Decrypt 18 unique views
Palantir CTO Says AI Researchers Are Smoking to Signal Faith in Cancer Cure

Palantir Chief Technology Officer Shyam Sankar has claimed that some AI researchers have begun smoking cigarettes to demonstrate their confidence that artificial intelligence will eventually cure cancer, but he offered no evidence for the assertion.

Sankar made the comment during an appearance on CBS News’ “Face the Nation,” where host Margaret Brennan questioned his focus on the broader cultural and ideological debate around AI. He presented smoking as a symbolic wager: researchers, he said, were willing to accept the health risks because they believed future AI systems would be capable of curing the diseases those risks can cause.

No names, survey results or other supporting data were provided during the segment. The claim therefore remains an unsupported characterization of the AI research community rather than a documented trend.

A provocative argument about AI belief

Sankar used the discussion to criticize effective altruism, a movement associated with efforts to direct resources toward causes considered especially beneficial. He described it as a “millenarian doomsday cult” and referred to FTX founder Sam Bankman-Fried as the figure from the movement most familiar to many Americans.

He also invoked the philosophical idea of a god-shaped gap in the human heart. In Sankar’s framing, some AI researchers may be filling that space with the prospect of a machine god known as artificial general intelligence, or AGI. AGI is commonly used to describe a future AI system with broad, human-level capabilities across many tasks.

The remarks came from an executive at Palantir, a company that sells data-analysis software to governments and militaries and whose business relies heavily on AI. Sankar’s comments therefore form part of a wider argument about how the technology’s advocates describe its potential, as well as the risks and beliefs surrounding it.

Cancer claims meet public-health evidence

The health consequences of smoking are well established. The U.S. Centers for Disease Control and Prevention says smoking causes roughly one in three cancer deaths in the United States. Cigarette smoke contains at least 69 chemicals known to cause cancer, and smokers face about 25 times the lung-cancer risk of people who do not smoke, according to the agency.

The CDC also says that quitting reduces the risk of 12 types of cancer. For lung cancer specifically, the additional risk falls by half 10 to 15 years after a person stops smoking.

Those figures provide important context for Sankar’s analogy: smoking is not a neutral demonstration of confidence, but a behavior associated with substantial and measurable health risks. The source material does not establish that AI researchers are engaging in the behavior he described.

The idea that AI could cure cancer has also drawn criticism from within the industry. Anthropic CEO Dario Amodei said in August that promises AI will cure cancer have become more of a cliché than an inspiration. He argued that public trust would be earned by actually curing the disease, rather than by repeatedly making the claim.

What the polling says about AI confidence

The CBS poll cited during the interview showed a skeptical public mood. Half of Americans said AI would create more problems than it solves. By comparison, 29% said it would solve more problems than it creates, while 21% were unsure.

The same poll found that about 45% of respondents wanted the government to restrict AI’s use and development. Against that backdrop, a dramatic anecdote about researchers smoking to signal confidence does little to demonstrate public acceptance of the technology. It instead highlights the gap between industry enthusiasm and wider concerns about AI.

The debate extends beyond medical promises. IMF Managing Director Kristalina Georgieva recently warned that AI could affect 40% of jobs, while the source material also says insiders expect a major AI incident within a year. Neither point establishes what will happen, but both illustrate why AI’s economic and safety implications remain contentious.

Moneyiar market picture

Moneyiar market data as of October 13, 2026, at 20:39 +03:30 showed mixed performance among the listed assets:

  • eCash (XEC) was priced at $0.0000069553, down 2.59% over 24 hours and 12.61% over seven days.
  • AKEDO (AKE) traded at $0.0251707391, up 4.48% in 24 hours but down 13.74% over seven days.
  • Propy (PRO) stood at $0.3608134068, up 1.50% over 24 hours and down 1.33% over seven days.

AI Rig Complex (ARC), based on Moneyiar data recorded at 07:53 +03:30 on the same date, traded at $0.035091056. It had fallen 43.36% over 24 hours and 50.20% over seven days. These market figures describe price movements only and do not establish a connection between the assets and Sankar’s comments.

According to Decrypt, the CBS appearance placed Sankar’s claim in a broader conversation about whether AI companies can persuade the public through ambitious promises. For now, the assertion that researchers are smoking to show faith in an AI-led cancer cure remains unsupported, while the medical risks of smoking are documented by public-health authorities.

Source Decrypt Written by Moneyiar based on reporting from the cited source and Moneyiar market data.
Read original source ↗

Related news

Based on this story’s market and assets

Comments